# GAREM1

## Overview
GAREM1, or GRB2 associated regulator of MAPK1 subtype 1, is a gene that encodes an adaptor protein involved in critical cellular signaling pathways, particularly those mediated by the epidermal growth factor (EGF) receptor. The protein encoded by GAREM1 is characterized by its role in modulating the MAPK/ERK signaling pathway, which is essential for cell growth, differentiation, and proliferation (Tashiro2009GAREM; Nishino2015Functional). Structurally, the protein contains several domains, including a CABIT domain, a proline-rich region, and a SAM domain, which facilitate its interactions with other signaling molecules such as Grb2 and Shp2 (Tashiro2009GAREM; Nishino2015Functional). These interactions are crucial for the protein's function in cellular transformation and proliferation, as well as its involvement in cardiac function, where it influences the PR interval on electrocardiograms (Kim2017GAREM1). The protein's activity is regulated through post-translational modifications, including phosphorylation, which affects its interactions and subcellular localization (Nishino2015Functional). GAREM1's role in both oncological and cardiac contexts underscores its significance in health and disease.

## Structure
GAREM1 is a protein involved in cellular signaling pathways, particularly in the epidermal growth factor (EGF) receptor-mediated signaling. The primary structure of GAREM1 includes several important regions: an N-terminal CABIT domain, an internal proline-rich region, and a C-terminal SAM domain (Nishino2015Functional). The CABIT domain contains a nuclear localization sequence (NLS) and a 14-3-3 binding site, which is phosphorylation-dependent (Nishino2015Functional). The proline-rich region is crucial for interactions with SH3 domains of signaling molecules like Grb2, particularly between amino acid residues 498-550 (Tashiro2009GAREM). The SAM domain is known for mediating protein-protein interactions and forming oligomers (Nishino2015Functional).

Post-translational modifications of GAREM1 include phosphorylation at specific tyrosine residues, such as Tyr-453, which is essential for its function and interaction with proteins like Shp2 (Tashiro2009GAREM). The phosphorylation of serine 650 (S650) is also significant for 14-3-3 binding (Nishino2015Functional). Mutations in these phosphorylation sites can affect the protein's interactions and localization (Nishino2015Functional). GAREM1 also has splice variant isoforms, contributing to its structural and functional diversity.

## Function
GAREM1 is an adaptor protein involved in the epidermal growth factor (EGF) signaling pathway, playing a crucial role in cell signaling and the regulation of the MAPK/ERK pathway. It contains several domains, including the CABIT domain at the N-terminus and the SAM domain at the C-terminus, which are important for its function and subcellular localization (Nishino2015Functional). The CABIT domain includes a nuclear localization sequence (NLS) that is essential for the nuclear localization of GAREM1, and its interaction with 14-3-3ε affects this localization (Nishino2015Functional; Liu2021The).

GAREM1 interacts with proteins such as Grb2 and Shp2, facilitating the activation of Erk, a key player in cell growth and differentiation (Tashiro2009GAREM; Nishino2015Functional). The phosphorylation of specific tyrosine residues, such as Tyr-105 and Tyr-453, is crucial for its interaction with these proteins and the subsequent activation of Erk signaling (Tashiro2009GAREM). This interaction is important for cellular transformation and proliferation, as demonstrated by its role in promoting colony formation and cell proliferation in various cell types (Tashiro2009GAREM).

GAREM1 is also involved in cardiac function, influencing the PR interval on electrocardiograms by modulating electrical signals at the atrioventricular node (Kim2017GAREM1). This highlights its broader role in cellular growth, differentiation, and organismal outcomes.

## Clinical Significance
Mutations and alterations in the expression of the GAREM1 gene have been implicated in various clinical conditions, particularly in cardiac and oncological contexts. In cardiac function, GAREM1 has been associated with the regulation of the PR interval on electrocardiograms (ECGs). A genome-wide association study identified a significant link between GAREM1 and the PR interval, suggesting that changes in GAREM1 expression could influence cardiac conduction and potentially contribute to arrhythmias or other heart-related conditions (Kim2017GAREM1). This association is clinically significant as PR interval prolongation is a known risk factor for atrial fibrillation, a common cardiac arrhythmia (Kim2017GAREM1).

In oncology, GAREM1 is involved in cellular transformation through the activation of the extracellular signal-regulated kinase (Erk) signaling pathway. The expression of GAREM1 enhances Erk activation, which is crucial for cell proliferation and transformation, suggesting its potential role in cancer development. Alterations in GAREM1 expression levels have been linked to malignancy, as its expression promotes colony formation and cell proliferation in experimental models (Tashiro2009GAREM). These findings indicate that GAREM1 may play a role in tumorigenesis and could be a target for therapeutic interventions in cancer.

## Interactions
GAREM1, also known as GRB2 associated regulator of MAPK1 subtype 1, is an adaptor protein that participates in several key protein interactions within cellular signaling pathways. It interacts with the growth factor receptor-bound protein 2 (Grb2) through its proline-rich motifs, which are recognized by the SH3 domains of Grb2. This interaction is crucial for the activation of the extracellular signal-regulated kinase (Erk) signaling pathway, particularly following epidermal growth factor (EGF) stimulation (Tashiro2009GAREM).

GAREM1 also interacts with the protein tyrosine phosphatase Shp2, a positive regulator of Erk, in a phosphorylation-dependent manner. This interaction is facilitated by the phosphorylation of GAREM1 at tyrosine residues, notably Tyr-453, which is similar to the immunoreceptor tyrosine-based inhibitory motif (Tashiro2009GAREM).

Additionally, GAREM1 binds to the 14-3-3ε protein, which influences its subcellular localization. This interaction involves specific amino acid sequences and phosphorylation sites within GAREM1, such as the N-terminal region and the phosphorylation site S650 (Nishino2015Functional). These interactions highlight GAREM1's role in modulating cellular processes through its involvement in multiple signaling pathways.


## References


[1. (Tashiro2009GAREM) Kyoko Tashiro, Takumi Tsunematsu, Hiroko Okubo, Takeshi Ohta, Etsuko Sano, Emiko Yamauchi, Hisaaki Taniguchi, and Hiroaki Konishi. Garem, a novel adaptor protein for growth factor receptor-bound protein 2, contributes to cellular transformation through the activation of extracellular signal-regulated kinase signaling. Journal of Biological Chemistry, 284(30):20206–20214, July 2009. URL: http://dx.doi.org/10.1074/jbc.M109.021139, doi:10.1074/jbc.m109.021139. This article has 51 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M109.021139)

[2. (Nishino2015Functional) Tasuku Nishino, Ryota Matsunaga, and Hiroaki Konishi. Functional relationship between cabit, sam and 14-3-3 binding domains of garem1 that play a role in its subcellular localization. Biochemical and Biophysical Research Communications, 464(2):616–621, August 2015. URL: http://dx.doi.org/10.1016/j.bbrc.2015.07.024, doi:10.1016/j.bbrc.2015.07.024. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2015.07.024)

[3. (Liu2021The) Jiaqi Liu, Shengliang Cao, Guofei Ding, Bin Wang, Yingchao Li, Yuzhong Zhao, Qingyuan Shao, Jian Feng, Sidang Liu, Liting Qin, and Yihong Xiao. The role of 14‐3‐3 proteins in cell signalling pathways and virus infection. Journal of Cellular and Molecular Medicine, 25(9):4173–4182, April 2021. URL: http://dx.doi.org/10.1111/jcmm.16490, doi:10.1111/jcmm.16490. This article has 30 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/jcmm.16490)

[4. (Kim2017GAREM1) Hye Ok Kim, Ji Eun Lim, Myung Jun Kim, Ji-One Kang, Sung-Moon Kim, Jeong Min Nam, Jihoon Tak, Hiroaki Konishi, Tasuku Nishino, In Song Koh, Young-Ho Jin, Hyung Hwan Baik, Jin-Bae Kim, Mi Kyung Kim, Bo Youl Choi, Sang-Hak Lee, Yangsoo Jang, Jinho Shin, and Bermseok Oh. Garem1 regulates the pr interval on electrocardiograms. Journal of Human Genetics, 63(3):297–307, December 2017. URL: http://dx.doi.org/10.1038/s10038-017-0367-x, doi:10.1038/s10038-017-0367-x. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s10038-017-0367-x)